Global Latex Allergy Market

Latex Allergy Market Size, Share, Growth Analysis, By Diagnosis Type(Allergy Test and Skin Test), By Application(Allergic Contact Dermatitis, Systemic Reaction and Others), By Treatment(Allergy Medication and Epinephrine Injection), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35I2328 | Region: Global | Published Date: April, 2024
Pages: 220 | Tables: 85 | Figures: 71

Latex Allergy Market Competitive Landscape

Numerous multinational corporations that are integral to innovation and offer comprehensive solutions for latex allergy management define the competitive landscape of the global latex allergy market. Leading players with a broad selection of latex-free products and allergy diagnostics include 3M, Ansell Ltd., Top Glove Corporation Bhd, and Hartalega Holdings Berhad. These businesses make large investments in R&D to bring safer, more efficient substitutes for traditional latex products, improving patient comfort and safety. Their vast product portfolios and global activities provide them a strong market position and encourage competitive dynamics centred on market expansion and technological improvement.

Top Player’s Company Profiles

  • Nektar Therapeutics (US)
  • Dey Labs (US)
  • Novartis AG (Switzerland)
  • Boehringer-Ingelheim (Germany)
  • GlaxoSmithKline (UK)
  • 3M (US)
  • Aterica (Canada)
  • Allerayde UK Ltd (United Kingdom)
  • Sanofi (France)
  • Alcon Inc. (Switzerland)
  • Rocky Mountain Diagnostics (US)
  • Array (US)
  • Merck (US)
  • AstraZeneca (UK)
  • Johnson & Johnson (US)

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Latex Allergy Market size was valued at USD 1721.62 million in 2022, USD 1849.02 million in 2023 and is projected to grow USD 3047.69 million by 2031, growing at a CAGR of 7.4% in the forecast period (2024-2031).

Numerous multinational corporations that are integral to innovation and offer comprehensive solutions for latex allergy management define the competitive landscape of the latex allergy market. Leading players with a broad selection of latex-free products and allergy diagnostics include 3M, Ansell Ltd., Top Glove Corporation Bhd, and Hartalega Holdings Berhad. These businesses make large investments in R&D to bring safer, more efficient substitutes for traditional latex products, improving patient comfort and safety. Their vast product portfolios and activities provide them a strong market position and encourage competitive dynamics centred on market expansion and technological improvement. 'Nektar Therapeutics (US)', 'Dey Labs (US)', 'Novartis AG (Switzerland)', 'Boehringer-Ingelheim (Germany)', 'GlaxoSmithKline (UK)', '3M (US)', 'Aterica (Canada)', 'Allerayde UK Ltd (United Kingdom)', 'Sanofi (France)', 'Alcon Inc. (Switzerland)', 'Rocky Mountain Diagnostics (US)', 'Array (US)', 'Merck (US)', 'AstraZeneca (UK)', 'Johnson & Johnson (US)'

One major factor driving the growth of the latex allergy market is the increasing prevalence of latex allergies worldwide. increasing exposure to latex goods in healthcare settings, increasing individual awareness, and enhanced diagnostic capabilities are some of the factors contributing to the higher detection rates of latex allergy.

Addressing Latex Allergy Risks in Healthcare: Despite these advancements, it is important to remember that a significant portion of latex allergies are still typically diagnosed in medical institutions. Individuals who work in healthcare, patients undergoing surgery, and people who have frequently come into touch with medical equipment that contains latex are at a heightened risk of experiencing an adverse response to AM. When compared to other goods used in healthcare settings, this trend validates the importance and necessity of preventive measures.

North America is the largest market in the world according to the latex allergy market. By the end of the projected term in 2030, the latex allergy market in North America should have grown at a satisfying market rate and reached a significant market valuation. The second-largest market for latex allergy is in other well-known market regions, such as Europe. The current prediction period, which ends in 2030, calls for the European market to grow at an exceptional and elaborate rate. Additionally, additional well-known market regions are preparing for the industry's expansion throughout that time. Due to a rise in the use of latex disposables in its regional areas, such as China and India, the Asia-Pacific region is anticipated to become a key player in the market expansion.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Allergy Diagnostics Market
Buy Now GET FREE SAMPLE
Allergy Diagnostics and Therapeutics Market
Buy Now GET FREE SAMPLE
Allergy Immunotherapy Market
Buy Now GET FREE SAMPLE
Allergic Rhinitis Market
Buy Now GET FREE SAMPLE
Atopic Dermatitis Drugs Market
Buy Now GET FREE SAMPLE
Topical Drugs Market
Buy Now GET FREE SAMPLE
Multiplex Assay Market
Buy Now GET FREE SAMPLE
Dermocosmetics Skin Care Products Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Latex Allergy Market

Report ID: SQMIG35I2328

$5,300
BUY NOW GET FREE SAMPLE